UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.79B |
| 2 |
Meta Platforms (Facebook)
META
|
+$412M |
| 3 |
TAL Education Group
TAL
|
+$200M |
| 4 |
PPD
PPD, Inc. Common Stock
PPD
|
+$184M |
| 5 |
Intuit
INTU
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.43B |
| 2 |
NetEase
NTES
|
+$245M |
| 3 |
Goldman Sachs
GS
|
+$161M |
| 4 |
PPLI
People Inc
PPLI
|
+$114M |
| 5 |
Baidu
BIDU
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.43% |
| 2 | Consumer Discretionary | 14.2% |
| 3 | Healthcare | 13.11% |
| 4 | Financials | 11.12% |
| 5 | Communication Services | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FOCS
1926
DELISTED
Focus Financial Partners Inc. Class A
FOCS
| $715K | ﹤0.01% |
21,800
+4,600
| +27% | +$163K |
|
1927
Travere Therapeutics
TVTX
$5.78B
| $714K | ﹤0.01% |
38,685
+4,970
| +15% | +$96.6K |
|
1928
G-III Apparel Group
GIII
$1.5B
| $713K | ﹤0.01% |
54,367
+10,967
| +25% | +$132K |
|
1929
York Water
YORW
$514M
| $711K | ﹤0.01% |
+16,818
| New | +$770K |
|
1930
Patterson-UTI
PTEN
$3.76B
| $710K | ﹤0.01% |
249,200
-63,583
| -20% | -$234K |
|
1931
Vericel Corp
VCEL
$2.31B
| $709K | ﹤0.01% |
38,279
-605
| -2% | -$10K |
|
1932
Rocket Companies
RKT
$38.9B
| $709K | ﹤0.01% |
+35,578
| New | +$830K |
|
1933
Quince Therapeutics
QNCX
$29.5M
| $707K | ﹤0.01% |
71
+23
| +48% | +$209K |
|
1934
Immunovant
IMVT
$8.25B
| $704K | ﹤0.01% |
20,000
+11,100
| +125% | +$334K |
|
1935
Calix
CALX
$2.39B
| $703K | ﹤0.01% |
39,523
+4,800
| +14% | +$90.6K |
|
|
TEN
1936
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $702K | ﹤0.01% |
101,108
-1,534
| -1% | -$12.2K |
|
1937
Eagle Bancorp
EGBN
$845M
| $701K | ﹤0.01% |
26,149
| – | – |
|
|
LGF.A
1938
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $700K | ﹤0.01% |
73,847
| – | – |
|
1939
Provident Financial Services
PFS
$3.19B
| $698K | ﹤0.01% |
57,238
+11,320
| +25% | +$152K |
|
|
CBPO
1940
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $698K | ﹤0.01% |
6,278
+2,708
| +76% | +$291K |
|
1941
OFG Bancorp
OFG
$2.21B
| $695K | ﹤0.01% |
55,761
-190
| -0.3% | -$2.49K |
|
1942
Core Laboratories
CLB
$521M
| $694K | ﹤0.01% |
45,492
-6,569
| -13% | -$138K |
|
1943
Primoris Services
PRIM
$4.45B
| $694K | ﹤0.01% |
38,472
+2,820
| +8% | +$49.9K |
|
|
UCTT
1944
Ultra Clean Holdings
UCTT
$3.95B
| $693K | ﹤0.01% |
32,306
+2,282
| +8% | +$55.4K |
|
1945
Matthews International
MATW
$739M
| $693K | ﹤0.01% |
31,005
+20,012
| +182% | +$429K |
|
1946
Inseego
INSG
$90.5M
| $693K | ﹤0.01% |
6,716
-88
| -1% | -$10.2K |
|
1947
Rhythm Pharmaceuticals
RYTM
$7.96B
| $693K | ﹤0.01% |
31,964
+12,901
| +68% | +$296K |
|
1948
Seacoast Banking Corp of Florida
SBCF
$3.35B
| $692K | ﹤0.01% |
38,373
-825
| -2% | -$16K |
|
|
ARR
1949
Armour Residential REIT
ARR
$2.36B
| $690K | ﹤0.01% |
14,517
+1,008
| +7% | +$48.1K |
|
1950
OceanFirst Financial
OCFC
$1.91B
| $690K | ﹤0.01% |
50,367
-749
| -1% | -$11.8K |
|
Similar funds
UBS AM's Q3 2020 Portfolio in Review
As of Q3 2020, UBS AM held 2,541 positions worth $186B, up 14% from $164B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM's Q3 2020 filing shows 79 new, 1,449 increased, 718 reduced and 56 closed positions. Its largest new stake was State Street Technology Select Sector SPDR ETF: 1,973,762 shares worth $115M. The largest sale was Alibaba, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- UBS AM's largest Q3 2020 buy was State Street Technology Select Sector SPDR ETF: 1,973,762 shares worth $115M.
- UBS AM added most to Microsoft in Q3 2020, an estimated $2.79B increase.
- UBS AM's biggest Q3 2020 reduction was Alibaba, cutting an estimated $1.43B.
- UBS AM fully exited LogMein, Inc. in Q3 2020, selling an estimated $27.8M.
- UBS AM's ten largest holdings make up 26% of its $186B portfolio in Q3 2020.
- UBS AM opened 79 new positions and closed 56 in Q3 2020.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $186B.
Based on UBS AM's 13F filing for Q3 2020, filed 13 Nov 2020.